The protective effect of microrna-320 on left ventricular remodeling after myocardial ischemia-reperfusion injury in the rat model

International Journal of Molecular Sciences

Volumn 15, Issue 10, 2014, Pages 17442-17456

  Song, Chun Li ^a   Liu, Bin ^a   Diao, Hong Ying ^a   Shi, Yong Feng ^a   Li, Yang Xue ^a   Zhang, Ji Chang ^a   Lu, Yang ^a   Wang, Guan ^a   Liu, Jia ^a   Yu, Yun Peng ^a   Guo, Zi Yuan ^a   Wang, Jin Peng ^a   Zhao, Zhuo ^a   Liu, Jian Gen ^a   Liu, Yi Hang ^a   Liu, Zhi Xian ^a   Cai, Dan ^a   Li, Qian ^a  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Left ventricular remodeling; microRNA 320; Myocardial ischemia reperfusion injury

Indexed keywords

ANTAGOMIR; MICRORNA; MICRORNA 320; UNCLASSIFIED DRUG; ANTISENSE OLIGONUCLEOTIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; LEFT VENTRICULAR SYSTOLIC PRESSURE; MALE; NICK END LABELING; NONHUMAN; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; ECHOCARDIOGRAPHY; FIBROSIS; GENETICS; HEART MUSCLE; HEMODYNAMICS; METABOLISM; PATHOLOGY; UPREGULATION; WISTAR RAT;

RATTUS;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FIBROSIS; HEMODYNAMICS; MALE; MICRORNAS; MYOCARDIUM; OLIGORIBONUCLEOTIDES, ANTISENSE; RATS; RATS, WISTAR; REPERFUSION INJURY; UP-REGULATION; VENTRICULAR REMODELING;

EID: 84907822239     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151017442     Document Type: Article

References (53)

1. Santulli, G. Epidemiology of cardiovascular disease in the 21st century: Updated numbers and updated facts. J. Cardiovasc. Dis. 2013, 1, 1-2.
2. Pagidipati, N. J.; Gaziano, T. A. Estimating deaths from cardiovascular disease: A review of global methodologies of mortality measurement. Circulation 2013, 127, 749-756.
3. Goff, D. C., Jr.; Lloyd-Jones, D. M.; Bennett, G.; Coady, S.; D'Agostino, R. B., Sr.; Gibbons, R.; Greenland, P.; Lackland, D. T.; Levy, D.; O'Donnell, C. J.; et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the american college of cardiology/american heart association task force on practice guidelines. J. Am. Coll. Cardiol. 2014, 63, 2935-2959.
4. Hausenloy, D. J.; Yellon, D. M. Myocardial ischemia-reperfusion injury: A neglected therapeutic target. J. Clin. Investig. 2013, 123, 92-100.
5. Konstam, M. A.; Kramer, D. G.; Patel, A. R.; Maron, M. S.; Udelson, J. E. Left ventricular remodeling in heart failure: Current concepts in clinical significance and assessment. JACC Cardiovasc. Imaging 2011, 4, 98-108.
6. Burchfield, J. S.; Xie, M.; Hill, J. A. Pathological ventricular remodeling: Mechanisms: Part 1 of 2. Circulation 2013, 128, 388-400.
7. Ito, Y.; Ito, K.; Shiroto, T.; Tsuburaya, R.; Yi, G. J.; Takeda, M.; Fukumoto, Y.; Yasuda, S.; Shimokawa, H. Cardiac shock wave therapy ameliorates left ventricular remodeling after myocardial ischemia-reperfusion injury in pigs in vivo. Coron. Artery Dis. 2010, 21, 304-311.
8. Barallobre-Barreiro, J.; Didangelos, A.; Schoendube, F. A.; Drozdov, I.; Yin, X.; Fernandez-Caggiano, M.; Willeit, P.; Puntmann, V. O.; Aldama-Lopez, G.; Shah, A. M.; et al. Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury. Circulation 2012, 125, 789-802.
9. Di, Y.; Lei, Y.; Yu, F.; Changfeng, F.; Song, W.; Xuming, M. MicroRNAs expression and function in cerebral ischemia reperfusion injury. J. Mol. Neurosci. 2014, 53, 242-250.
10. Kuwabara, Y.; Ono, K.; Horie, T.; Nishi, H.; Nagao, K.; Kinoshita, M.; Watanabe, S.; Baba, O.; Kojima, Y.; Shizuta, S.; et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ. Cardiovasc. Genet. 2011, 4, 446-454.
11. Duisters, R. F.; Tijsen, A. J.; Schroen, B.; Leenders, J. J.; Lentink, V.; van der Made, I.; Herias, V.; van Leeuwen, R. E.; Schellings, M. W.; Barenbrug, P.; et al. miR-133 and miR-30 regulate connective tissue growth factor: Implications for a role of microRNAs in myocardial matrix remodeling. Circ. Res. 2009, 104, 170-178.
12. Olson, E. N. MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease. Sci. Transl. Med. 2014, 6, 239ps3.
13. Fic, P.; Kowalczuk, K.; Grabarska, A.; Stepulak, A. MicroRNA-A new diagnostic tool in coronary artery disease and myocardial infarction. Postepy Hig. Med. Dosw. Online 2014, 68, 410-418.
14. Topkara, V. K.; Mann, D. L. Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc. Drugs Ther. 2011, 25, 171-182.
15. Ye, Y.; Perez-Polo, J. R.; Qian, J.; Birnbaum, Y. The role of microRNA in modulating myocardial ischemia-reperfusion injury. Physiol. Genomics 2011, 43, 534-542.
16. Wang, X.; Zhang, X.; Ren, X. P.; Chen, J.; Liu, H.; Yang, J.; Medvedovic, M.; Hu, Z.; Fan, G. C. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 2010, 122, 1308-1318.
17. Qin, Y.; Yu, Y.; Dong, H.; Bian, X.; Guo, X.; Dong, S. MicroRNA 21 inhibits left ventricular remodeling in the early phase of rat model with ischemia-reperfusion injury by suppressing cell apoptosis. Int. J. Med. Sci. 2012, 9, 413-423.
18. Li, B.; Li, R.; Zhang, C.; Bian, H. J.; Wang, F.; Xiao, J.; Liu, S. W.; Yi, W.; Zhang, M. X.; Wang, S. X.; et al. MicroRNA-7a/b protects against cardiac myocyte injury in ischemia/reperfusion by targeting poly(ADP-ribose) polymerase. PLoS One 2014, 9, e90096.
19. Vandenberg, J. I.; Perry, M. D.; Perrin, M. J.; Mann, S. A.; Ke, Y.; Hill, A. P. hERG K(+) channels: Structure, function, and clinical significance. Physiol. Rev. 2012, 92, 1393-1478.
20. White, R. E.; Giffard, R. G. MicroRNA-320 induces neurite outgrowth by targeting ARPP-19. Neuroreport 2012, 23, 590-595.
21. Semin, B. K.; Ivanov, II; Rubin, A. B. Tetracaine inhibition of electron transport in pea chloroplasts is coupled to calcium displacement by the local anesthetic. Gen. Physiol. Biophys. 1990, 9, 65-70.
22. Ren, X. P.; Wu, J.; Wang, X.; Sartor, M. A.; Qian, J.; Jones, K.; Nicolaou, P.; Pritchard, T. J.; Fan, G. C. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 2009, 119, 2357-2366.
23. Thum, T.; Galuppo, P.; Wolf, C.; Fiedler, J.; Kneitz, S.; van Laake, L. W.; Doevendans, P. A.; Mummery, C. L.; Borlak, J.; Haverich, A.; et al. MicroRNAs in the human heart: A clue to fetal gene reprogramming in heart failure. Circulation 2007, 116, 258-267.
24. Ikeda, S.; Kong, S. W.; Lu, J.; Bisping, E.; Zhang, H.; Allen, P. D.; Golub, T. R.; Pieske, B.; Pu, W. T. Altered microRNA expression in human heart disease. Physiol. Genomics 2007, 31, 367-373.
25. Kim, A. S.; Johnston, S. C. Global variation in the relative burden of stroke and ischemic heart disease. Circulation 2011, 124, 314-323.
26. Frank, A.; Bonney, M.; Bonney, S.; Weitzel, L.; Koeppen, M.; Eckle, T. Myocardial ischemia reperfusion injury: From basic science to clinical bedside. Semin. Cardiothorac. Vasc. Anesth. 2012, 16, 123-132.
27. Vilahur, G.; Juan-Babot, O.; Pena, E.; Onate, B.; Casani, L.; Badimon, L. Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction. J. Mol. Cell. Cardiol. 2011, 50, 522-533.
28. Galiuto, L.; de Caterina, A. R.; Porfidia, A.; Paraggio, L.; Barchetta, S.; Locorotondo, G.; Rebuzzi, A. G.; Crea, F. Reversible coronary microvascular dysfunction: A common pathogenetic mechanism in Apical Ballooning or Tako-Tsubo Syndrome. Eur. Heart J. 2010, 31, 1319-1327.
29. Herrmann, J.; Kaski, J. C.; Lerman, A. Coronary microvascular dysfunction in the clinical setting: From mystery to reality. Eur. Heart J. 2012, 33, 2771-2782.
30. Vollmar, B.; Menger, M. D. Intestinal ischemia/reperfusion: Microcirculatory pathology and functional consequences. Langenbecks Arch. Surg. 2011, 396, 13-29.
31. Santulli, G.; Cipolletta, E.; Sorriento, D.; del Giudice, C.; Anastasio, A.; Monaco, S.; Maione, A. S.; Condorelli, G.; Puca, A.; Trimarco, B.; et al. CaMK4 gene deletion induces hypertension. J. Am. Heart Assoc. 2012, 1, e001081.
32. Jain, M.; Upadaya, S.; Zarich, S. W. Serial evaluation of microcirculatory dysfunction in patients with Takotsubo cardiomyopathy by myocardial contrast echocardiography. Clin. Cardiol. 2013, 36, 531-534.
33. Oka, T.; Akazawa, H.; Naito, A. T.; Komuro, I. Angiogenesis and cardiac hypertrophy: Maintenance of cardiac function and causative roles in heart failure. Circ. Res. 2014, 114, 565-571.
34. Miyazaki, Y.; Ikeda, Y.; Shiraishi, K.; Fujimoto, S. N.; Aoyama, H.; Yoshimura, K.; Inui, M.; Hoshijima, M.; Kasahara, H.; Aoki, H.; et al. Heart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodeling. PLoS One 2012, 7, e35875.
35. Samuel, S. M.; Thirunavukkarasu, M.; Penumathsa, S. V.; Koneru, S.; Zhan, L.; Maulik, G.; Sudhakaran, P. R.; Maulik, N. Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats. Circulation 2010, 121, 1244-1255.
36. Divakaran, V.; Mann, D. L. The emerging role of microRNAs in cardiac remodeling and heart failure. Circ. Res. 2008, 103, 1072-1083.
37. Weiss, J. B.; Eisenhardt, S. U.; Stark, G. B.; Bode, C.; Moser, M.; Grundmann, S. MicroRNAs in ischemia-reperfusion injury. Am. J. Cardiovasc. Dis. 2012, 2, 237-247.
38. Takahama, H.; Shigematsu, H.; Asai, T.; Matsuzaki, T.; Sanada, S.; Fu, H. Y.; Okuda, K.; Yamato, M.; Asanuma, H.; Asano, Y.; et al. Liposomal amiodarone augments anti-arrhythmic effects and reduces hemodynamic adverse effects in an ischemia/reperfusion rat model. Cardiovasc. Drugs Ther. 2013, 27, 125-132.
39. Santulli, G.; Iaccarino, G.; de Luca, N.; Trimarco, B.; Condorelli, G. Atrial fibrillation and microRNAs. Front. Physiol. 2014, 5, 15.
40. Callis, T. E.; Pandya, K.; Seok, H. Y.; Tang, R. H.; Tatsuguchi, M.; Huang, Z. P.; Chen, J. F.; Deng, Z.; Gunn, B.; Shumate, J.; et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Investig. 2009, 119, 2772-2786.
41. Shan, H.; Li, X.; Pan, Z.; Zhang, L.; Cai, B.; Zhang, Y.; Xu, C.; Chu, W.; Qiao, G.; Li, B.; et al. Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1. Br. J. Pharmacol. 2009, 158, 1227-1235.
42. Ali, N.; Rizwi, F.; Iqbal, A.; Rashid, A. Induced remote ischemic pre-conditioning on ischemia-reperfusion injury in patients undergoing coronary artery bypass. J. Coll. Physicians Surg. Pak. 2010, 20, 427-431.
43. Toldo, S.; Seropian, I. M.; Mezzaroma, E.; van Tassell, B. W.; Salloum, F. N.; Lewis, E. C.; Voelkel, N.; Dinarello, C. A.; Abbate, A. Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 2011, 51, 244-251.
44. Fan, Q.; Chen, M.; Zuo, L.; Shang, X.; Huang, M. Z.; Ciccarelli, M.; Raake, P.; Brinks, H.; Chuprun, K. J.; Dorn, G. W., 2nd.; et al. Myocardial ablation of G protein-coupled receptor kinase 2 (GRK2) decreases ischemia/reperfusion injury through an anti-intrinsic apoptotic pathway. PLoS One 2013, 8, e66234.
45. Gidlöf, O.; Smith, J. G.; Miyazu, K.; Gilje, P.; Spencer, A.; Blomquist, S.; Erlinge, D. Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. BMC Cardiovasc. Disord. 2013, 13, 12.
46. Zhu, H.; Fan, G. C. Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovasc. Res. 2012, 94, 284-292.
47. Ho, C. Y.; Lopez, B.; Coelho-Filho, O. R.; Lakdawala, N. K.; Cirino, A. L.; Jarolim, P.; Kwong, R.; Gonzalez, A.; Colan, S. D.; Seidman, J. G.; et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N. Engl. J. Med. 2010, 363, 552-563.
48. Goldsmith, E. C.; Bradshaw, A. D.; Spinale, F. G. Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: Moving beyond collagen expression. Am. J. Physiol. Cell Physiol. 2013, 304, C393-C402.
49. Porter, K. E.; Turner, N. A. Cardiac fibroblasts: At the heart of myocardial remodeling. Pharmacol. Ther. 2009, 123, 255-278.
50. Yu, S.; Li, G. MicroRNA expression and function in cardiac ischemic injury. J. Cardiovasc. Transl. Res. 2010, 3, 241-245.
51. Schaar, D. G.; Medina, D. J.; Moore, D. F.; Strair, R. K.; Ting, Y. miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation. Exp. Hematol. 2009, 37, 245-255.
52. Lorenzen, J. M.; Kielstein, J. T.; Hafer, C.; Gupta, S. K.; Kumpers, P.; Faulhaber-Walter, R.; Haller, H.; Fliser, D.; Thum, T. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin. J. Am. Soc. Nephrol. 2011, 6, 1540-1546.
53. Salloum, F. N.; Yin, C.; Kukreja, R. C. Role of microRNAs in cardiac preconditioning. J. Cardiovasc. Pharmacol. 2010, 56, 581-588.